Kgnu - How On Earth

We talk with scientists who report that a common weight loss/diabetes drug known as a GLP-1 receptor agonist (Wegovy, Ozempic for instance) is associated with an increased risk of blindness.  The study was published last week in the Journal of the American Medical Association Ophthalmology, about a form of blindness known as “wet” macular degeneration.  … Continue reading "GLP-1 and Blindness"